Skip to main content
. 2020 Apr 10;7(5):ofaa120. doi: 10.1093/ofid/ofaa120

Table 4.

Independent Predictors of In-Hospital Mortality Among Patients with Streptococcal IE

Variable Unadjusted OR (95% CI) P Adjusted OR (95% CI) P
Age, per 1-y increment 1.02 (1.01–1.04) <.005 1.03 (1.01–1.04) <.005
Diabetes 1.94 (1.24–3.02) .004
HIV infection 5.13 (1.86–14.10) .002 9.27 (2.90–29.62) <.005
Native valve predisposition 0.58 (0.39–0.87) .008
PCN-susceptible streptococcus 0.62 (0.42–0.93) .02
PVIE 1.89 (1.25–2.87) .003
Paravalvular complication 2.38 (1.64–3.46) <.005 2.58 (1.72–3.89) <.005
CHF 4.18 (2.89–6.04) <.005 4.94 (3.36–7.27) <.005
CHF (NYHA Class III or IV) 4.11 (2.83–5.98) <.005
Stroke 4.03 (2.74–5.93) <.005 4.81 (3.14–7.35) <.005
Etiology
 BHS IE 2.49 (1.53–4.05) <.005
S. pneumonia 1.85 (0.75–4.54) .18
 Bovis group streptococci 1.10 (0.68–1.76) .70
 VGS (reference) 1

Variables in the multivariate model: age per 1-year increment, diabetes, HIV infection, native valve predisposition, PVIE, paravalvular complication, CHF, stroke, and etiology. Final multivariate model: age per 1-year increment, HIV infection, PVIE, paravalvular complication, congestive heart failure, stroke (Hosmer-Lemeshow goodness of fit, 0.869; AUC, 0.8; Clustering coefficient [Cp], 9.950).

Abbreviations: AUC, area under the curve; BHS, beta-hemolytic streptococci; CHF, congestive heart failure; CI, confidence interval; IE, infective endocarditis; OR, odds ratio; NYHA, New York Heart Association; PCN, penicillin; PVIE, prosthetic valve infective endocarditis; VGS, viridans group streptococci.